Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLiabilities from Discontinued OperationsLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Standard Biotools (LAB) Convertible Debt (2016 - 2026)

Standard Biotools has reported Convertible Debt over the past 12 years, most recently at $299000.0 for Q4 2025.

  • Quarterly Convertible Debt changed 0.0% to $299000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $299000.0 through Dec 2025, changed 0.0% year-over-year, with the annual reading at $299000.0 for FY2025, 0.0% changed from the prior year.
  • Convertible Debt was $299000.0 for Q4 2025 at Standard Biotools, roughly flat from $299000.0 in the prior quarter.
  • Over five years, Convertible Debt peaked at $55.0 million in Q3 2023 and troughed at $299000.0 in Q1 2024.
  • The 5-year median for Convertible Debt is $44.7 million (2021), against an average of $29.1 million.
  • Year-over-year, Convertible Debt soared 53.51% in 2023 and then crashed 99.46% in 2024.
  • A 5-year view of Convertible Debt shows it stood at $54.2 million in 2021, then grew by 0.84% to $54.6 million in 2022, then tumbled by 98.96% to $569000.0 in 2023, then crashed by 47.45% to $299000.0 in 2024, then changed by 0.0% to $299000.0 in 2025.
  • Per Business Quant, the three most recent readings for LAB's Convertible Debt are $299000.0 (Q4 2025), $299000.0 (Q3 2025), and $299000.0 (Q2 2025).